# P&I Investment

> P&I Investment is a VC fund in Seongnam backing Media and Entertainment and TV. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Seongnam, South Korea
- Total investments: 5
- Last investment: Nov 2024
- Lead investor: 20%
- Last updated: Aug 2026

P&I Investment is a venture capital firm based in South Korea.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $8.4M–$36M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Media and Entertainment | 2 | 40% |
| TV | 1 | 20% |
| Music | 1 | 20% |
| Video | 1 | 20% |
| Content | 1 | 20% |

18 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 60% |
| Seed | 2 | 40% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| CLUSH | Clush is an AI and cloud infrastructure company that builds enterprise software to help organizations develop, deploy, and manage AI systems. The company offers cloud-native services and products, enabling customers to build, manage, and collaborate on cloud-based applications and data. Clush provides products such as Clush Kube MLOps, AIgovernance platforms, AI agents, hybrid cloud infrastructure, and enterprise collaboration tools for industries including finance, manufacturing, and public sector organizations | $14.3M | Series A | Nov 20, 2024 |  |
| OASYS STUDIO | ​OASYS STUDIO is a cloud-native visual effects company that integrates VFX pipeline services and production within a cloud environment. They offer scalable and efficient production solutions, fostering stable collaboration structures for clients. | $4.7M | Seed | Jul 12, 2023 |  |
| Contents Technologies | Content Technologies is a content IP-based company builder. | $36.2M | Series A | Nov 18, 2022 |  |
| Novelty Nobility | Novelty Nobility Inc. is a private biotech company. They are currently focused on the research of novel angiogenesis targets and develop antibody-based therapeutics in ophthalmology and oncology, where angiogenesis plays a key pathogenic role.In ophthalmology, Novelty Nobility first discovered a novel angiogenesis target, Stem Cell Factor(SCF)and c-KIT, which was initially known for its engagement with proliferation and survival of primitive hematopoietic stem cells for a couple of past decades. We believe that anti-SCF/c-KIT could effectively address the unmet medical needs, mostly caused by inherent limitations of anti-VEGFs, in terms of treatment efficacy and long-term safety. Our target discovery is widely and strongly patent-protected in US/KOR and the lead pipeline, NN2101(a full-human monoclonal antibody), is currently under preclinical development. | $8.4M | Series A | Feb 04, 2020 |  |
| NeoTany | NeoTany creates digital animated content for various channels and platforms. |  | Seed | Aug 27, 2019 |  |

5 of 5 investments shown.

## Co-investors
- [Shinhan Venture Investment](https://shizune.co/investors/profile/shinhan-venture-investment) — VC Fund, 2 deals together
- [SV Investment Corp](https://shizune.co/investors/profile/sv-investment-corp) — VC Fund, 2 deals together
- [AON Investment](https://shizune.co/investors/profile/aon-investment) — VC Fund, 1 deal together
- [Bigbang Angels](https://shizune.co/investors/profile/bigbang-angels-inc) — VC Fund, 1 deal together
- [BSK Investment](https://shizune.co/investors/profile/bsk-investment-7237) — VC Fund, 1 deal together
- [CJ OliveNetworks](https://shizune.co/investors/profile/cj-olivenetworks-004e) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Life Science VC Funds in South Korea](https://shizune.co/investors/life-science-vc-funds-south-korea)
- [Music VC Funds in South Korea](https://shizune.co/investors/music-vc-funds-south-korea)

## FAQ

### What does P&I Investment invest in?

P&I Investment invests primarily in Media and Entertainment, TV and Music startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is P&I Investment's check size?

P&I Investment typically joins rounds of $8.4M–$36M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds P&I Investment participates in.

### When did P&I Investment last invest?

The most recent investment recorded for P&I Investment closed in Nov 2024. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co